MEDNAX acquires Neonatology Center of Winchester

MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Neonatology Center of Winchester, P.C., a neonatal physician group practice based in Winchester, Va. The practice will become part of MEDNAX's Pediatrix Medical Group division, a national group practice consisting of the nation's leading neonatal, maternal-fetal medicine, pediatric cardiology, and other pediatric specialty physicians.

Established in 1996, Neonatology Center of Winchester is a private practice which exclusively provides a wide spectrum of services including neonatal intensive care, transport services as well as maternal, emergency room, and newborn nursery consults at Winchester Medical Center, a Level III, 30-bed neonatal intensive care unit (NICU).

"Joining Pediatrix will afford us the opportunity to continue to develop quality improvement efforts in the care of babies while they are hospitalized, enhance research and education initiatives, as well as place energy into community and legislative efforts that affect change for their futures," said Teresa Clawson, M.D., Medical Director of Neonatology Services at Winchester Medical Center.

The practice was acquired for cash and the transaction is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.

With this acquisition, ten physician group practices have become part of MEDNAX in 2013, five as part of Pediatrix Medical Group, and five as part of American Anesthesiology.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can vitamin D3 supplementation reduce COVID-19 severity?